Quick Answer
Aprea Therapeutics, Inc. reported Net Income of -$12.60 million for fiscal year 2025.
Aprea Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$12.60M | +2.8% |
| 2024 | -$12.96M | +9.3% |
| 2023 | -$14.29M | +87.3% |
| 2022 | -$112.66M | -203.4% |
| 2021 | -$37.13M | +30.6% |
| 2020 | -$53.48M | -90.6% |
| 2019 | -$28.06M | -80.7% |
| 2018 | -$15.53M | -2.2% |
| 2017 | -$15.19M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.97M | +21.4% | +8.2% |
| June 30, 2025 | -$3.24M | +6.7% | +17.6% |
| March 31, 2025 | -$3.93M | -39.9% | -3.9% |
| September 30, 2024 | -$3.78M | -18.1% | -9.0% |
| June 30, 2024 | -$3.47M | -6.5% | -23.5% |
| March 31, 2024 | -$2.81M | +35.8% | +12.3% |
| September 30, 2023 | -$3.20M | +20.4% | +1.7% |
| June 30, 2023 | -$3.26M | +96.7% | +25.6% |
- Aprea Therapeutics, Inc. showed an increase of +2.8% in Net Income compared to the prior fiscal year.
- Over the 2017–2025 period, Aprea Therapeutics, Inc.’s net income has grown by 17.1% (from -$15.19 million to -$12.60 million).
- The most recent figure is from Aprea Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: